Implantable Biosensor Developed at URMC
A new device created at the University of Rochester could provide physicians with real time information about the health of their patients.
A new device created at the University of Rochester could provide physicians with real time information about the health of their patients.
Raland’s CytoComm™ technology has been issued another patent.
Raland Therapeutics featured in Democrat & Chronicle headline news article.
Raland Therapeutics is a finalist in the $5M 43North competition.
Raland Therapeutics is one of the eleven finalists in a worldwide business competition
Raland Therapeutics Inc. was selected as a semi-finalist in the 43North Business competition.
Our transformative technology platform will dramatically reduce R&D costs.
Efferent Labs® offers a live, cellular data acquisition platform that will radically alter the landscape of pre-clinical research in animals.
Sign up for email alerts of Press Releases and Efferent Labs’ breaking news